文献速递皮肤肿瘤

痣相关肢端黑色素瘤复发与死亡风险低于新发肢端黑色素瘤:482例多中心回顾性分析

Nevus-associated acral melanoma has lower risk of recurrence and mortality than de novo acral melanoma: A multicenter, retrospective analysis of 482 patients.
PubMed 文献 · J Am Acad Dermatol · 2024-11-20

该多中心回顾性队列研究纳入2011年2月至2022年11月诊断的肢端黑色素瘤患者,比较痣相关肢端黑色素瘤(NAAM)与新发肢端黑色素瘤(DNAM)的复发和死亡风险。结果显示NAAM占34.0%,其复发风险和死亡风险均显著低于DNAM,且痣相关是RFS和OS的独立预后因素。

要点

  • NAAM患者占34.0%,其复发风险显著低于DNAM(HR 0.69)。
  • NAAM死亡风险显著低于DNAM(HR 0.53)。
  • 痣相关是RFS和OS的独立预后因素。

核心结论

  • 痣相关肢端黑色素瘤患者的无复发生存率和总生存率均显著优于新发肢端黑色素瘤患者。
  • 痣相关是RFS和OS的独立预后因素。

研究设计与样本

  • 多中心回顾性队列研究,纳入2011年2月至2022年11月诊断的肢端黑色素瘤患者482例。

主要发现

  • 164例(34.0%)为痣相关肢端黑色素瘤(NAAM)。
  • NAAM的5年无复发生存率为55.1%,DNAM为42.3%。
  • NAAM的5年总生存率为75.1%,DNAM为63.2%。

关键数值与推荐

  • 多因素分析确定Breslow厚度、痣相关和哨兵淋巴结状态是RFS的独立预测因素。
  • 年龄、Breslow厚度、痣相关、淋巴血管侵犯、溃疡和哨兵淋巴结状态是OS的独立预测因素。

临床怎么用

  • 对于肢端黑色素瘤患者,应评估是否与痣相关,以辅助预后判断。
  • 痣相关肢端黑色素瘤患者可能具有更好的生存预期,但仍需根据其他独立预后因素综合管理。

局限性

  • 研究为回顾性设计。
  • 存在数据缺失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unknown whether acral melanomas (AMs) associated with pre-existing nevi have similar risk to other AMs. OBJECTIVE: To compare risk of recurrence and death between AMs associated with pre-existing nevi and de novo AMs. METHODS: We conducted a multicenter retrospective cohort study involving patients diagnosed with AMs between February 2011 and November 2022. RESULTS: About 164 patients (34.0%) had nevus-associated acral melanoma (NAAM). NAAM has lower risk of recurrence (hazard ratio: 0.69; 95% CI: 0.52-0.91; P = .008) and mortality (hazard ratio: 0.53; 95% CI: 0.37-0.76; P < .001) than de novo acral melanoma (DNAM). The 5-year recurrence-free survival (RFS) was 55.1% for NAAM compared to 42.3% for DNAM. The 5-year overall survival (OS) was 75.1% for NAAM and 63.2% for DNAM. Multivariate analyses identified Breslow thickness, nevus association, and sentinel node status as independent predictors of RFS. Age, Breslow thickness, nevus association, lymphovascular invasion, ulceration, and sentinel node status were independent predictors of OS. LIMITATIONS: The study's limitations included its retrospective design and missing data. CONCLUSION: Patients with nevus-associated AMs had significantly better RFS and OS compared to those with de novo AMs. Nevus association was an independent prognostic factor for both RFS and OS.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Wu J, Cai X, et al. Nevus-associated acral melanoma has lower risk of recurrence and mortality than de novo acral melanoma: A multicenter, retrospective analysis of 482 patients. J Am Acad Dermatol. 2024. PMID: 39577696. doi:10.1016/j.jaad.2024.11.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。